Thus, there was an overall 6% prevalence of germline SDHB/D variants in the combined datasets comprising 754 thyroid cancer patients compared with 0/350 of our residential population controls (P<0.001) (Table 1). The gene discussed is SDHB; the disease is thyroid cancer.